Chapter Eleven - Monsanto Marriage

CHAPTER ELEVEN

Monsanto Marriage

IN 2018, BAYER made a move no one saw coming.

It bought Monsanto.

The deal was massive, over $60 billion. One of the biggest corporate mergers in pharmaceutical and agricultural history. Bayer was already a global name in both industries, but Monsanto came with something else: control over seeds, genetically modified crops, and one of the most controversial products in the world. Roundup.

Public reaction was immediate.

Monsanto had spent decades as a villain in environmental circles. It was known for aggressive lawsuits against farmers, harsh patent enforcement, and the widespread use of glyphosate, the key ingredient in Roundup. Critics linked it to cancer, ecological damage, and corporate overreach.

By acquiring Monsanto, Bayer inherited all of it. The products, the market share, and the lawsuits.

Thousands of them.

Bayer insisted the science was clear. Regulators had approved glyphosate. The product was safe. The merger was about innovation and efficiency, not control. But to many, it looked like something else: a chemical superpower swallowing its rival and consolidating the global food chain.

The backlash didn’t stop the merger.

It made Bayer bigger. More powerful. More exposed.

What had started as a coal tar dye company was now the single most influential player in both medicine and agriculture. It sold you the drugs. It sold you the food. And now, it owned the seeds.

The risk was enormous.

So were the profits.